PFIZER INC Cash Provided by (Used in) Financing Activities, Discontinued Operations
PFIZER INC (PFE) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2023-02-23
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for the quarter ending 2021-10-03 was $0.00.
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for the quarter ending 2020-12-31 was $596.00M.
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for the quarter ending 2020-09-27 was -$57.00M.
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for fiscal 2022 was $0.00.
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for fiscal 2020 was $11.99B.
- PFIZER INC cash provided by (used in) financing activities, discontinued operations for fiscal 2019 was $0.00.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | |
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2021-07-04 | $0.00 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $596.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $539.00M derived: sum of 2 quarters · filed 2023-02-23 | $11.99B 10-K · filed 2023-02-23 | |
| 2020-09-27 | -$57.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $11.39B 10-Q · filed 2021-11-12 | ||
| 2020-06-28 | $11.45B 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |